Tritech Group Limited Announces S\$3 Million Multi-Tranche Placement and Option Agreement

Key Highlights and Potential Impact for Shareholders

Tritech Group Limited (“Tritech” or the “Company”) has unveiled a significant fundraising initiative via a multi-tranche placement and option agreement with private investor Tay Tong Yee, Terence (the “Placee”). This strategic transaction, entered into on 2 April 2026, could result in the issuance of up to 285,714,285 new ordinary shares, representing approximately 15.18% of the Company’s current share capital and about 13.18% of the enlarged share capital post-completion, assuming all options are exercised at the minimum (floor) price.

Structure of the Proposed Transactions

1. First Tranche – Immediate Placement
   • The Placee will subscribe for 95,238,095 new shares at S\$0.0105 per share, raising S\$1,000,000.
   • This issue price reflects a 31.25% premium to the Company’s volume-weighted average price (VWAP) of S\$0.0080 on the last trading day prior to the agreement.
   • Tranche 1 shares will represent approximately 5.06% of existing share capital.
2. Second Tranche – Call and Put Option (Oct 2026)
   • The Placee and the Company mutually grant call and put options for the Placee to subscribe for another 95,238,095 shares at either the floor price of S\$0.0105 or a 10% discount to the VWAP at the time of exercise, whichever is higher.
   • The Tranche 2 option window is 1–15 October 2026.
   • This second tranche, if exercised at the floor price, will raise another S\$1,000,000.
3. Third Tranche – Call and Put Option (Apr 2027)
   • An additional 95,238,095 shares may be issued under similar terms during the window of 1–15 April 2027.
   • If exercised at the floor price, this will raise a further S\$1,000,000.

Shareholder-Impacting Details and Potential Price Sensitivities

• Potential Dilution: If all tranches and options are exercised, the Placee could own up to 13.18% of the enlarged Company. Existing shareholders will see a corresponding dilution of their holdings, with the issued share capital rising to 2,168,444,927 shares.
• Premium Placement Price: The issue price for all shares (in all three tranches, if exercised at floor price) is at a significant premium to the latest market price, which may be viewed positively as a sign of confidence.
• No Change in Control: The transaction will not result in any transfer of controlling interest in the Company.
• Appointment of Placee as Director: Upon completion of the third tranche, and subject to due diligence, Tay Tong Yee, Terence will join the Board as a non-executive director. This may provide the Company with new strategic input and business networks.
• Use of Proceeds: The S\$3 million raised (before estimated expenses of S\$31,000) will be deployed for general working capital, including staff salaries, professional fees, and overheads—critical for the Company’s ongoing operations and financial stability.
• Financial Effects: The net tangible asset (NTA) per share will improve from S\$0.26 cents to S\$0.36 cents if all shares are issued. However, EPS will decrease marginally from S\$0.0019 to S\$0.0016 due to the increase in share count.
• Conditions and Risks: Each tranche is subject to various conditions precedent, including regulatory and shareholder approvals, SGX listing and quotation notice (LQN), and no material adverse change in the Company’s position. Failure to satisfy these could result in the lapse of the respective tranches.
• Flexibility and Downside Protection: The call and put options allow either party to require the issuance or subscription of shares, providing flexibility and downside protection.
• Exercise Price Adjustment: The exercise price will only be adjusted in the event of a share consolidation, not for other changes like bonus or rights issues (unless otherwise agreed in writing).
• General Mandate: The shares to be issued across all tranches fall within the limits of the Company’s existing general mandate approved at the July 2025 AGM.
• Termination Rights: Both the Company and the Placee have rights to terminate the agreement under certain adverse scenarios, including material breach, insolvency, trading suspension, or material adverse changes.

Disclosure Relating to the Placee

• The Placee is a private investor with no prior shareholding or connections to the Company, its directors, or substantial shareholders, as warranted in the agreement.
• The Placee is subscribing as a principal for his own benefit and is not acting in concert with any other party.

Strategic Rationale

The Board considers this fundraising move both prudent and beneficial, especially given prior modest placements and the prevailing challenging market environment. The capital injected will reinforce liquidity, support ongoing operations, and underpin future growth initiatives. The Board also welcomes the opportunity to tap into the Placee’s network for additional business opportunities.

What Should Shareholders Watch For?

• Potential Share Price Movement: The premium issue price, substantial capital injection, and impending Board changes are all developments that the market is likely to react to.
• Announcements on Tranche Completions: Shareholders should expect periodic updates as each tranche is completed or if any conditions are not met.
• Utilisation of Proceeds: The Company will provide regular breakdowns on how the new funds are being used, especially for working capital.
• Appointment of Placee to Board: This could signal new strategic directions or partnerships.

Cautionary Note

While the multi-tranche placement and options agreement is a significant move for the Company, shareholders and potential investors are advised that there is no certainty the proposed transactions will be completed, nor that the terms will remain unchanged. The Company will make further announcements as material developments arise.

Summary Table: Shareholding Impact

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should consult their professional advisors before taking any action. The information is based on Company announcements and may be subject to change. There is no assurance that the proposed transactions will be completed as described.

View Tritech Historical chart here